Nasdaq: RXRX

Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker RXRX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
RXRX
Exchange
Nasdaq
SEC CIK
1601830
Official filings
SEC EDGAR

Research RXRX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Recursion Pharmaceuticals, Inc.'s stock ticker?

Recursion Pharmaceuticals, Inc. trades under the ticker symbol RXRX on Nasdaq. Its SEC Central Index Key (CIK) is 1601830.

Where can I read Recursion Pharmaceuticals, Inc.'s SEC filings?

The RXRX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Recursion Pharmaceuticals, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze RXRX's financial statements?

The RXRX Financials page shows Recursion Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does RXRX compare with its peers and the market?

The RXRX Peer Comparison page lines Recursion Pharmaceuticals, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.